- All sections
- C - Chemistrymetallurgy
- C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
- C12P 21/04 - Cyclic or bridged peptides or polypeptides, e.g. bacitracin
Patent holdings for IPC class C12P 21/04
Total number of patents in this class: 931
10-year publication summary
|
56
|
22
|
27
|
27
|
22
|
16
|
8
|
10
|
5
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4337 |
11 |
| Abbvie Inc. | 1800 |
11 |
| Novozymes A/S | 3329 |
9 |
| Codexis, Inc. | 801 |
9 |
| Regeneron Pharmaceuticals, Inc. | 4323 |
9 |
| Novartis AG | 10730 |
8 |
| The Regents of the University of California | 20059 |
8 |
| California Institute of Technology | 3985 |
8 |
| Ajinomoto Co., Inc. | 2291 |
8 |
| Bunge Oils, Inc. | 121 |
8 |
| Shanghai Techwell Biopharmaceutical Co., Ltd. | 67 |
8 |
| The University of Tokyo | 4200 |
8 |
| Genentech, Inc. | 3994 |
7 |
| Ambrx, Inc. | 183 |
7 |
| CJ Cheiljedang Corporation | 3441 |
7 |
| Gevo, Inc. | 263 |
7 |
| Allergan, Inc. | 2337 |
6 |
| President and Fellows of Harvard College | 5995 |
6 |
| Novartis Vaccines and Diagnostics, Inc. (a Delaware corporation) | 32 |
5 |
| Amgen Inc. | 4106 |
5 |
| Other owners | 776 |